18 Years On, Lab’s Stem Cell Breakthrough Fuels Search for Diabetes Cure – Laboratory Equipment
Laboratory Equipment |
18 Years On, Lab’s Stem Cell Breakthrough Fuels Search for Diabetes Cure
Laboratory Equipment Once Doug Melton’s young children were diagnosed with type I diabetes, he turned his research efforts at Harvard toward turning stem cells into transplantable tissue. Eighteen years later, a breakthrough in Melton’s lab became the basis for Semma … |
Singularity Hub |
Researchers Repair Brain Damage in Mice With Stem Cell Transplants
Singularity Hub The human brain is a biological wonder with considerable skills. Regeneration, unfortunately, isn’t one of them. Save for one tiny V-shaped region within the hippocampus, the human brain’s ability to rebuild itself is nearly nonexistent. When neurons … |
|
These companies want to use Stem Cells to improve Drug Safety
Labiotech.eu (blog) Axiogenesis is a Biotech from Cologne, Germany, that develops cell lines derived from induced pluripotent stem cells (iPSCs) for preclinical applications. The company has announced a collaboration with Metrion Biosciences, which is located in the UK’s … |
Genetic Engineering & Biotechnology News (press release) |
Domain Swaps Lessen Autoimmunity in TCR Gene Therapy
Genetic Engineering & Biotechnology News (press release) On the surface of the T cell, one T-cell receptor (TCR) type has the makings of an immune party, but two TCRs could be a crowd. A second TCR type can be disruptive, a cause of autoimmunity. Or it can be the life of the party, the instigator of an … |
fox8.com |
Ohio stem cell procedure offering hope to NFL players with multiple concussions
fox8.com CLEVELAND – An experimental stem cell procedure is offering hope to NFL players who have suffered multiple concussions. “Using things that come out of my body to regenerate things and help me feel better it’s absolutely a no brainer,” said former NFL … |
DailyTech |
UTHealth Clinical Trial Shows Progress Using Stem Cells to Treat Traumatic Brain Injury
DailyTech Results of phase 1 clinical trial conducted by researchers from University of Texas Health Memorial Hermann Hospital showed that it’s possible to reduce brain inflammation by using stem cells from patient’s own bone marrow to reduce the … |